$7.41
4.02% today
Nasdaq, Jul 02, 08:43 pm CET
ISIN
US53630X1046
Symbol
LPCN
Sector
Industry

Lipocine, Inc. Target price 2024 - Analyst rating & recommendation

Lipocine, Inc. Classifications & Recommendation:

Buy
100%

Lipocine, Inc. Target price

Target price $33.00
Course $7.72
Price potential
Number of estimates 1
1 Analyst has issued a Lipocine, Inc. price target 2025. The average Lipocine, Inc. target price is $33.00. This is higher than the current share price.
A rating was issued by 1 analysts: 1 Analysts recommend Lipocine, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Lipocine, Inc. share has an average upside potential 2025 of . Most analysts recommend the Lipocine, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 0.11 8.95
78.00% 8,037.27%
Net margin -15,186.18% -59.43%
589.50% 99.61%

1 Analyst has issued a sales forecast Lipocine, Inc. 2024 . The average Lipocine, Inc. sales estimate is

$9.0m
Unlock
. This is
16.70% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$9.0m 16.70%
Unlock
, the lowest is
$9.0m 16.70%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $110k 78.00%
2024
$9.0m 8,037.27%
Unlock
2025
$16.3m 81.58%
Unlock

1 Analyst has issued a net profit forecast Lipocine, Inc. 2024 . The average Lipocine, Inc. net profit estimate is

$-5.3m
Unlock
. This is
41.86% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-5.3m 41.86%
Unlock
, the lowest is
$-5.3m 41.86%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-16.7m 51.69%
2024
$-5.3m 68.15%
Unlock
2025
$-320k 93.98%
Unlock

Net margin

2023 -15,186.18% 589.50%
2024
-59.43% 99.61%
Unlock
2025
-1.96% 96.70%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -3.14 -1.00
51.69% 68.15%
P/E ratio negative
EV/Sales 1.86

1 Analysts have issued a Lipocine, Inc. forecast for earnings per share. The average Lipocine, Inc. <a href=/blog/eps>EPS is

$-1.00
Unlock
. This is
41.86% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-1.00 41.86%
Unlock
, the lowest is
$-1.00 41.86%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-3.14 51.69%
2024
$-1.00 68.15%
Unlock
2025
$-0.06 94.00%
Unlock

P/E ratio

Current -4.48 89.83%
2024
-7.72 72.32%
Unlock
2025
-128.67 1,566.71%
Unlock

Based on analysts' sales estimates for 2024, the Lipocine, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 2.17 145.40%
2024
1.86 14.23%
Unlock
2025
1.03 44.93%
Unlock

P/S ratio

Current 5.38 88.72%
2024
4.61 14.31%
Unlock
2025
2.54 44.93%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today